CompletedNCT05588635

Association Between Live Birth Rate and Serum Progesterone During Hormonal Replacement Therapy

Studying Ovarian hyperstimulation syndrome

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Centre Hospitalier Régional Metz-Thionville
Principal Investigator: Ariane GOUTALAND, MD
CHR Metz Thionville Hopital de Mercy
Intervention: Identification of predictive factors(other)
Enrollment: 168 target
Eligibility: 18-43 years · FEMALE
Timeline: 2019 – 2021

Study locations (1)

CHR Metz-Thionville/Hopital de Mercy, Metz, France

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05588635 on ClinicalTrials.gov

Other trials for Ovarian hyperstimulation syndrome

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE2NCT07043322
Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation Syndrome
Tanta University

See all trials for Ovarian hyperstimulation syndrome →

← Back to all trials